Drug
Bmn 111
Bmn 111: highest development phase Phase 3, developed by BioMarin Pharmaceutical. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- BioMarin Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| BMN 111 NCT03424018 | Phase 3 | Achondroplasia |
| BMN 111 NCT02724228 | Phase 2 | Achondroplasia |
| BMN 111 NCT02055157 | Phase 2 | Achondroplasia |
Latest
No recent events.
Follow Bmn 111 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.